Research and Markets: Global Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) Therapeutics Pipeline Review, H1 2015 - 14 Companies & 16 Drug Profiles

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/3zhcrw/idiopathic) has announced the addition of the "Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H1 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies Involved in Therapeutics Development

  • Anthera Pharmaceuticals Inc.
  • Azano Pharmaceuticals Inc.
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb Company
  • Eisai Co., Ltd.
  • GlaxoSmithKline plc
  • HanAll Biopharma Co., Ltd.
  • Immunomedics, Inc.
  • Merck & Co., Inc.
  • Momenta Pharmaceuticals, Inc.
  • Pfizer Inc.
  • PhytoHealth Corporation
  • Rigel Pharmaceuticals, Inc.
  • SuppreMol GmbH

Drug Profiles

  • Antibody for Autoimmune Disorders and Inflammation
  • avatrombopag
  • AZ-175
  • belimumab
  • BI-655064
  • blisibimod
  • BMS-986004
  • eltrombopag olamine
  • fostamatinib disodium
  • GL-2045
  • GSK-2285921
  • HL-161
  • MK-8723
  • PHN-013
  • SM-101
  • veltuzumab

For more information visit http://www.researchandmarkets.com/research/3zhcrw/idiopathic

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Cardiovascular

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Cardiovascular